OPPM
TENX icon

Opus Point Partners Management’s Tenax Therapeutics TENX Stock Holding History

Opus Point Partners Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8
Closed -$812K – 65
2015
Q1 		$812K Hold
8
– – 0.68% 39
2014
Q4 		$956K Buy
+8
New +$968K 0.95% 31

Other funds holding TENX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opus Point Partners Management's TENX Position: Q2 2015 in Review

Opus Point Partners Management sold out of Tenax Therapeutics (TENX) in Q2 2015, closing a stake of 8 shares — an estimated $812K sold.

Opus Point Partners Management first reported a position in TENX in Q4 2014 and held it in 2 quarters. The position peaked at $956K in Q4 2014. 16 funds tracked by Wall St. Rank hold TENX as of Q2 2015.

  • Opus Point Partners Management reported no remaining Tenax Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 8 Tenax Therapeutics shares in Q2 2015, an estimated $812K.
  • Opus Point Partners Management first reported a position in Tenax Therapeutics in Q4 2014 and held it in 2 quarters.
  • Opus Point Partners Management's Tenax Therapeutics position peaked at $956K in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2015.

Based on Opus Point Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.